WELCURE
Invest Now
Start SIP in
WELCURE
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
Investment Returns
- Over 1 Month -3.08%
- Over 3 Month -5.67%
- Over 6 Month + 14.56%
- Over 1 Year + 100.23%
Smart Investing Starts Here Start SIP with Welcure Drugs & Pharmaceuticals for Steady Growth!
Welcure Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Welcure Drugs & Pharmaceuticals Financials
Welcure Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹8.81
-0.33
(-3.61%)
-
- Bearish Moving Average 0
-
- Bullish Moving Average 0
- 20 Day
- ₹8.54
- 50 Day
- ₹8.72
- 100 Day
- ₹8.63
- 200 Day
- ₹7.81
Resistance and Support
9.03
- R3 10.27
- R2 9.93
- R1 9.37
- S1 8.47
- S2 8.13
- S3 7.57
Welcure Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-14 | Quarterly Results | |
2024-11-14 | Quarterly Results | (Revised) |
2024-10-21 | Others | |
2024-08-14 | Quarterly Results | |
2024-06-10 | Others | Inter alia, 1. To augment of financial resources of the company, 2. To increase in authorised share capital of the company and 3. To shift branch office of the company. |
Welcure Drugs & Pharmaceuticals F&O
About Welcure Drugs & Pharmaceuticals
- NSE Symbol
- WELCURE
- BSE Symbol
- 524661
- Managing Director & CFO
- Mr. Altaf Hussain Shah
- ISIN
- INE331C01017
Similar Stocks to Welcure Drugs & Pharmaceuticals
Welcure Drugs & Pharmaceuticals FAQs
Welcure Drugs & Pharmaceuticals share price is ₹8 As on 02 May, 2025 | 04:29
The Market Cap of Welcure Drugs & Pharmaceuticals is ₹99.1 Cr As on 02 May, 2025 | 04:29
The P/E ratio of Welcure Drugs & Pharmaceuticals is 52.5 As on 02 May, 2025 | 04:29
The PB ratio of Welcure Drugs & Pharmaceuticals is 1 As on 02 May, 2025 | 04:29
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.